Biopharmaceutical Innovator in Protein Degradation
us
Arvinas is a Biopharmaceutical Innovator in Protein Degradation.
Last updated
Arvinas is a clinical-stage biopharmaceutical company focused on developing targeted protein degradation therapeutics. Utilizing its proprietary PROTAC® Discovery Engine, Arvinas engineers therapies designed to degrade disease-causing proteins, addressing conditions like metastatic castrate-resistant prostate cancer and ER+/HER2- breast cancer. The company shares updates on its clinical programs and research advancements across platforms.
Leading the way in targeted protein degradation therapeutics
Favikon helps you find the right creators, analyze them in depth, reach out at scale, and track what works.
